Folks, this is the result for the 48 week treatment arms with and without lead-in. It is far better than its interim data reported at EASL. It is still an SVR at 12 wk post-treatment.
Right, if Telaprevir did 24 weeks with SOC or had a 4 week lead in, then it would be a more clean comparison. That was my point, T was dosed 12 weeks, B was dosed 24. If SGP had done a 12+12, that would also have worked.
No, you're wrong. Tel. was dosed for 12 weeks, Boc. for 24 to 28. I knew when I left out "up to 28" you'd jump on that.
12 weeks of Tel. +12 weeks SOC is not equal to 24 or 28 weeks of Boc. with SOC. How you can say that 12 weeks dosing of one drug vs. 24 or 28 weeks dosing of another drug is equal, I have no idea.
It isn't apples to apples, and I think you know that.
But Dew, I own this stock. A fair amount of it too. So you lecturing about investment vs. patient advocacy is irrelevant in my case.
And I have not seen any mention from you about the time frame of the rather rigid FDA requirements and Vertex vs. SGP progress with those requirements. Less than responsive on your part...
Hey, those 4 week lead-in results are impressive....I have a hunch when results for teleprevir arm with 4 week lead-in are announced it boost svr12 or svr24 for Telaprevir another 10 points or so... which means it still blow SGP out of the water.
get a grip? Without the FDA approval, without jumping thru all the hoops, I don't get to do 24 or 28 weeks of anything! No matter how sick or how quick the progression. Right now, in the real world, I have access to only 48 weeks of treatment.
SGP is still far far behind Vertex and is not a viable option for me. There's a bunch of us that don't really care what the name of the drug is...as soon as it is approved...we're on board.
It's all a matter of time...months matter in my case and a lot more of us too. Failed SOC advances fibrosis pretty quickly and add advancing age...well, there will be a bit of a pop for Telaprevir in it's first months of approval.
I think it is pretty funny that a year ago you were arguing the efficacy of telaprevir. Now telaprevir is the drug to beat? Thanks for the giggle today....it's good to keep the perspective straightened up.